GFAP and infantile neuronal ceroid lipofuscinosis: Hindering GFAP palmitoylation rescue both astrogliosis and neurodegenerative pathology in PPT1-KI mice and hereby offer palm-C291 in GFAP as a possible pharmaceutical target for curing INCL and other possible neurodegenerative diseases.